Related Experiment Videos
Depression of the immune responsiveness in mice treated with thioacetamide after antigen exposure
G Malvaldi1, G Batoni, P Marelli
1Institute of General Pathology, University of Pisa, Italy.
Abstract:
The effects of the weak carcinogen thioacetamide (TAA) on the mouse immune response have been investigated. TAA administration up to 1 day after antigen priming markedly suppressed the antibody response to both T-dependent (sheep erythrocytes) and T-independent (trinitrophenyl-Ficoll) antigens; the compound was ineffective when given 3 or 4 days after immunization. A significant suppression of the in vitro lymphoproliferative response to the B-cell mitogen S. aureus Cowan I was evident from 3 to 48 h after TAA treatment. On the other hand, cell-mediated immune response to oxazolone was suppressed by TAA at each time tested, including that of challenge. The in vitro lymphoproliferative response to concanavalin A was decreased 12 h after TAA administration only, when adenosine deaminase activity within lymphocytes was increased. Furthermore, TAA is endowed with anti-inflammatory activity, as shown by the decreased footpad swelling and by evaluation of the inflammatory cell infiltration upon carrageenan injection. Taken together, these findings suggest selective TAA interaction with multiple targets within the immune system, including B- and T-lymphocytes, while non-specific cytotoxicity can be reasonably ruled out, since hematological determinations and phenotypic analysis of spleen lymphocyte subsets showed no relevant changes.
Insights
The weak carcinogen thioacetamide (TAA) suppresses mouse antibody and cell-mediated immune responses, affecting both B- and T-lymphocytes. TAA also exhibits anti-inflammatory properties, indicating selective immune system interactions.
Area of Science:
- Immunology
- Toxicology
- Pharmacology
Background:
- Thioacetamide (TAA) is a weak carcinogen.
- Its effects on the immune system are not fully understood.
Purpose of the Study:
- To investigate the impact of TAA on various components of the mouse immune response.
- To determine the temporal effects and specificity of TAA's immunomodulatory actions.
Main Methods:
- Mice were immunized with T-dependent (sheep erythrocytes) and T-independent (trinitrophenyl-Ficoll) antigens.
- In vitro lymphoproliferative assays were performed using B-cell mitogens (S. aureus Cowan I) and T-cell mitogens (concanavalin A).
- Cell-mediated immunity was assessed using oxazolone, and anti-inflammatory effects were evaluated via carrageenan-induced paw edema.
Main Results:
- TAA administration suppressed antibody responses when given up to 1 day post-immunization.
- Significant suppression of B-cell proliferation was observed from 3 to 48 hours post-TAA treatment.
- Cell-mediated immunity was suppressed at all tested times, and TAA demonstrated anti-inflammatory activity.
- Selective effects on lymphocytes were noted, with no significant changes in hematology or spleen lymphocyte subsets, ruling out general cytotoxicity.
Conclusions:
- TAA selectively interacts with multiple immune targets, including B- and T-lymphocytes.
- The compound exhibits both immunosuppressive and anti-inflammatory effects.
- Non-specific cytotoxicity is unlikely given the observed selective immune modulation.